Both in Pharmaceuticals
Harrow vs Latigo Biotherapeutics
Over the past year HROW returned −17.2% and LTGO returned −34.2%; their daily moves had a correlation of 0.31.
HROW −17.2% LTGO −34.2%Growth of $1, one year, split-adjusted
| Metric | HROW | LTGO |
|---|---|---|
| Price | $28.54 | $14.57 |
| Market cap | $1.07B | $966.0M |
| Today | +1.21% | +7.85% |
| 1 month | −6.7% | −12.4% |
| 6 months | −29.5% | — |
| Year to date | −41.8% | — |
| 1 year | −24.4% | — |
| Revenue growth (YoY) | +10.9% | — |
| Gross margin | 71.3% | — |
| Net margin | −24.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | — |
| Net cash | -$208.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 40.2% | — |
| Short % of float | 24.3% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).